Development of bozepinib-loaded nanocapsules for nose-to-brain delivery: preclinical evaluation in glioblastoma

被引：7
|
作者：
Dias, Amanda de Fraga [1 ]
Dallemole, Danieli Rosane [2 ]
Bruinsmann, Franciele Aline [2 ]
Lopes Silva, Luiz Fernando [1 ]
Cruz-Lopez, Olga [3 ,4 ]
Conejo-Garcia, Ana [3 ,4 ]
Oliveira Battastini, Ana Maria [1 ]
Maria Campos, Joaquin [3 ,4 ]
Guterres, Silvia Staniscuaski [2 ]
Pohlmann, Adriana Raffin [2 ]
Figueiro, Fabricio [1 ,5 ]
机构：
[1] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Programa Posgrad Ciencias Biol Bioquim, Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande do Sul, Fac Farm, Programa Posgrad Ciencias Farmaceut, Porto Alegre, RS, Brazil
[3] Fac Farm, Dept Quim Farmaceut & Organ, C Campus Cartuja S-N, Granada, Spain
[4] Inst Invest Biosanitaria Granada Ibs GRANADA, Granada, Spain
[5] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Bioquim, Porto Alegre, RS, Brazil
来源：
NANOMEDICINE | 2021年 / 16卷 / 23期
关键词：
bozepinib; drug delivery; glioblastoma; intranasal; lipid-core nanocapsules; temozolomide; LIPID-CORE NANOCAPSULES; DRUG-DELIVERY; POLYMERIC NANOPARTICLES; INTRANASAL DELIVERY; EXPERIMENTAL-DESIGN; GROWTH-INHIBITION; IN-VITRO; CHITOSAN; COMBINATION; GLIOMA;
D O I：
10.2217/nnm-2021-0164
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Aim: To develop and characterize bozepinib-loaded lipid-core nanocapsules (BZP-LNC+) as a potential treatment for glioblastoma (GBM). Methods: Characterization of nanocapsules was performed by diameter, polydispersity index, zeta potential, pH and encapsulation efficiency. GBM cell viability, cell cycle and Annexin/PI were evaluated after BZP-LNC+ treatment. Synergism between BZP-LNC+ and temozolomide (TMZ) was performed by CompuSyn software and confirmed in vitro and in vivo. Results: BZP-LNC+ showed adequate particle sizes, positive zeta potential, narrow size distribution and high encapsulation efficiency. BZP-LNC+ reduces GBM growth by inducing apoptosis. BZP-LNC+ and TMZ showed synergistic effect in vitro and reduced the in vivo glioma growth by approximately 81%. Conclusion: The present study provides proof-of-principle insights for the combination of these drugs for GBM treatment.
引用
收藏
页码：2095 / 2115
页数：21
相关论文
共 50 条
  • [1] EGFRvIII peptide nanocapsules and bevacizumab nanocapsules: a nose-to-brain multitarget approach against glioblastoma
    de Cristo Soares Alves, Aline
    Lavayen, Vladimir
    de Fraga Dias, Amanda
    Bruinsmann, Franciele Aline
    Scholl, Juliete Nathali
    Ce, Rodrigo
    Visioli, Fernanda
    Oliveira Battastini, Ana Maria
    Staniscuaski Guterres, Silvia
    Figueiro, Fabricio
    Raffin Pohlmann, Adriana
    NANOMEDICINE, 2021, 16 (20) : 1775 - 1790
  • [2] Nose-to-Brain Delivery of Cancer-Targeting Paclitaxel-Loaded Nanoparticles Potentiates Antitumor Effects in Malignant Glioblastoma
    Ullah, Irfan
    Chung, Kunho
    Bae, Sumin
    Li, Yan
    Kim, Chunggu
    Choi, Boyoung
    Nam, Hye Yeong
    Kim, Sun Hwa
    Yun, Chae-Ok
    Lee, Kuen Yong
    Kumar, Priti
    Lee, Sang-Kyung
    MOLECULAR PHARMACEUTICS, 2020, 17 (04) : 1193 - 1204
  • [3] Nanosystems at Nexus: Navigating Nose-to-Brain Delivery for Glioblastoma Treatment
    Agnihotri, Tejas Girish
    Dahifale, Akanksha
    Gomte, Shyam Sudhakar
    Rout, Biswajit
    Peddinti, Vasu
    Jain, Aakanchha
    MOLECULAR PHARMACEUTICS, 2025, 22 (02) : 599 - 619
  • [4] Nose-to-brain delivery of temozolomide-loaded PLGA nanoparticles functionalized with anti-EPHA3 for glioblastoma targeting
    Chu, Liuxiang
    Wang, Aiping
    Ni, Ling
    Yan, Xiuju
    Song, Yina
    Zhao, Mingyu
    Sun, Kaoxiang
    Mu, Hongjie
    Liu, Sha
    Wu, Zimei
    Zhang, Chunyan
    DRUG DELIVERY, 2018, 25 (01) : 1634 - 1641
  • [5] Nose-to-Brain Delivery
    Wang, Zian
    Xiong, Guojun
    Tsang, Wai Chun
    Schatzlein, Andreas G.
    Uchegbu, Ijeoma F.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2019, 370 (03) : 593 - 601
  • [6] Nanoparticles for direct nose-to-brain delivery of drugs
    Mistry, Alpesh
    Stolnik, Snjezana
    Illum, Lisbeth
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 379 (01) : 146 - 157
  • [7] Development of Atomoxetine-Loaded NLC In Situ Gel for Nose-to-Brain Delivery: Optimization, In Vitro, and Preclinical Evaluation
    Mohanty, Dibyalochan
    Alsaidan, Omar Awad
    Zafar, Ameeduzzafar
    Dodle, Trishala
    Gupta, Jeetendra Kumar
    Yasir, Mohd
    Mohanty, Anshuman
    Khalid, Mohammad
    PHARMACEUTICS, 2023, 15 (07)
  • [8] Increased Nose-to-Brain Delivery of Melatonin Mediated by Polycaprolactone Nanoparticles for the Treatment of Glioblastoma
    de Oliveira Junior, Edilson Ribeiro
    Nascimento, Thais Leite
    Salomao, Mariana Arraes
    Garcia da Silva, Artur Christian
    Valadares, Marize Campos
    Lima, Eliana Martins
    PHARMACEUTICAL RESEARCH, 2019, 36 (09)
  • [9] Fabrication, Optimization, and Evaluation of Rotigotine-Loaded Chitosan Nanoparticles for Nose-To-Brain Delivery
    Tzeyung, Angeline Shak
    Md, Shadab
    Bhattamisra, Subrat Kumar
    Madheswaran, Thiagarajan
    Alhakamy, Nabil A.
    Aldawsari, Hibah M.
    Radhakrishnan, Ammu K.
    PHARMACEUTICS, 2019, 11 (01):
  • [10] Nose-to-brain delivery: exploring newer domains for glioblastoma multiforme management
    Upadhaya, Prashant G.
    Pulakkat, Sreeranjini
    Patravale, Vandana B.
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2020, 10 (04) : 1044 - 1056
12345